Tricia Hultgren, MD
Dermatology · Omaha, NENPI 1740494806
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 47.1% of the total. Reporting peaked in 2024 at $486 and has fallen 78.3% since, to $105 in 2025. That places this record below the midpoint for dermatology clinicians in NE, where the typical reported total is $2,089.
Across 45 payments — averaging $21.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$457
- E.r. Squibb & Sons, L.L.C.$277
- Johnson & Johnson$56
- Sanofi$55
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$24
- LEO Pharma Inc.$23
- plus $77 from 5 others
What the payments were for
- Food & beverage$969100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $457 |
| E.r. Squibb & Sons, L.L.C. | 19 | $277 |
| Johnson & Johnson | 3 | $56 |
| Sanofi | 2 | $55 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| LEO Pharma Inc. | 1 | $23 |
| Biofrontera Inc. | 1 | $20 |
| Novartis | 1 | $17 |
| Amgen | 1 | $14 |
| Galderma Laboratories, L.p. | 1 | $14 |
| Pfizer | 1 | $12 |
How this compares
$969 in reported general payments places this provider in the 35th percentile of 68 dermatology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx SyringeSecukinumab | 12 | $89,361 |
| Clobetasol Propionate | 39 | $2,990 |
| Metronidazole | 42 | $2,151 |
| Fluorouracil | 26 | $2,027 |
| Ketoconazole | 112 | $1,687 |
| Dutasteride | 42 | $1,039 |
| Betamethasone Dipropionate | 22 | $909 |
| Minoxidil | 104 | $804 |
| Doxycycline Hyclate | 39 | $774 |
| Triamcinolone Acetonide | 60 | $610 |
| MethotrexateMethotrexate Sodium | 52 | $576 |
| Clindamycin Phosphate | 18 | $520 |
| Fluocinonide | 12 | $461 |
| Mometasone Furoate | 15 | $394 |
| ValacyclovirValacyclovir Hcl | 15 | $393 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Omaha
- Rachel PersonOmaha$98K
- Erin BarrettOmaha$96K
- Joel SchlessingerOmaha$89K
- Mathew DaveyOmaha$35K
- Gage RenschOmaha$11K
- Herschel StollerOmaha$10K
- Deirdre StolmeierOmaha$10K
- Melissa DarlingOmaha$10K
- Christopher HuerterOmaha$7K
- Tina KinsleyOmaha$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.